Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Fletcher

Showing results (771-780 of 805) with videos related to

Pageof 81
Sort By:
The New Phytologist|June 1, 2022
A group of CLE peptides regulates de novo shoot regeneration in Arabidopsis thalianaJingke Kang, Xuening Wang, Takashi Ishida, et al.
Cancer Cell|March 16, 2005
DJ-1, a novel regulator of the tumor suppressor PTENRaymond H Kim, Malte Peters, YingJu Jang, et al.
Neuroimage|January 4, 2014
Structural neuroimaging correlates of allelic variation of the BDNF val66met polymorphismNatalie J Forde, Lisa Ronan, John Suckling, et al.
Oncogenesis|September 17, 2022
PFKFB4 interacts with FBXO28 to promote HIF-1α signaling in glioblastomaEmma Phillips, Jörg Balss, Frederic Bethke, et al.
The American Journal of Psychiatry|January 8, 2020
A Population-Based Cohort Study Examining the Incidence and Impact of Psychotic Experiences From Childhood to Adulthood, and Prediction of Psychotic DisorderSarah A Sullivan, Daphne Kounali, Mary Cannon, et al.
Cancers|January 13, 2021
A Set of Cell Lines Derived from a Genetic Murine Glioblastoma Model Recapitulates Molecular and Morphological Characteristics of Human TumorsBarbara Costa, Michael N C Fletcher, Pavle Boskovic, et al.
Schizophrenia Research|May 12, 2020
Reinforcement learning as an intermediate phenotype in psychosis? Deficits sensitive to illness stage but not associated with polygenic risk of schizophrenia in the general populationMarcella Montagnese, Franziska Knolle, Joost Haarsma, et al.
Journal of Clinical Pharmacology|August 13, 2013
The effects of alcohol on the pharmacokinetics and pharmacodynamics of the selective mu-opioid receptor antagonist GSK1521498 in healthy subjectsHisham Ziauddeen, Pradeep J Nathan, Chris Dodds, et al.
Abdominal Radiology (New York)|December 18, 2024
Discordance between MR enterography and endoscopic detection of Crohn's disease ileal strictures: evidence to inform recommendationsMariana Yalon, Payam Mohammadinejad, Akitoshi Inoue, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2010
Phase I safety, pharmacokinetic, and pharmacodynamic study of ENMD-2076, a novel angiogenic and Aurora kinase inhibitor, in patients with advanced solid tumorsJennifer R Diamond, Bruno R Bastos, Ryan J Hansen, et al.
Pageof 81

Showing results (771-780 of 805) with videos related to

Sort By:
Pageof 81
The New Phytologist|June 1, 2022
A group of CLE peptides regulates de novo shoot regeneration in Arabidopsis thalianaJingke Kang, Xuening Wang, Takashi Ishida, et al.
Cancer Cell|March 16, 2005
DJ-1, a novel regulator of the tumor suppressor PTENRaymond H Kim, Malte Peters, YingJu Jang, et al.
Neuroimage|January 4, 2014
Structural neuroimaging correlates of allelic variation of the BDNF val66met polymorphismNatalie J Forde, Lisa Ronan, John Suckling, et al.
Oncogenesis|September 17, 2022
PFKFB4 interacts with FBXO28 to promote HIF-1α signaling in glioblastomaEmma Phillips, Jörg Balss, Frederic Bethke, et al.
The American Journal of Psychiatry|January 8, 2020
A Population-Based Cohort Study Examining the Incidence and Impact of Psychotic Experiences From Childhood to Adulthood, and Prediction of Psychotic DisorderSarah A Sullivan, Daphne Kounali, Mary Cannon, et al.
Cancers|January 13, 2021
A Set of Cell Lines Derived from a Genetic Murine Glioblastoma Model Recapitulates Molecular and Morphological Characteristics of Human TumorsBarbara Costa, Michael N C Fletcher, Pavle Boskovic, et al.
Schizophrenia Research|May 12, 2020
Reinforcement learning as an intermediate phenotype in psychosis? Deficits sensitive to illness stage but not associated with polygenic risk of schizophrenia in the general populationMarcella Montagnese, Franziska Knolle, Joost Haarsma, et al.
Journal of Clinical Pharmacology|August 13, 2013
The effects of alcohol on the pharmacokinetics and pharmacodynamics of the selective mu-opioid receptor antagonist GSK1521498 in healthy subjectsHisham Ziauddeen, Pradeep J Nathan, Chris Dodds, et al.
Abdominal Radiology (New York)|December 18, 2024
Discordance between MR enterography and endoscopic detection of Crohn's disease ileal strictures: evidence to inform recommendationsMariana Yalon, Payam Mohammadinejad, Akitoshi Inoue, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2010
Phase I safety, pharmacokinetic, and pharmacodynamic study of ENMD-2076, a novel angiogenic and Aurora kinase inhibitor, in patients with advanced solid tumorsJennifer R Diamond, Bruno R Bastos, Ryan J Hansen, et al.
Pageof 81